Skip to main navigation
Skip to search
Skip to main content
King's College London Home
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Datasets
Impacts
Prizes
Search by expertise, name or affiliation
CAR T cell immunotherapy of epithelial ovarian cancer: past, present and a view of the horizon
Jana Obajdin
,
John Maher
Comprehensive Cancer Centre
Research output
:
Contribution to journal
›
Review article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CAR T cell immunotherapy of epithelial ovarian cancer: past, present and a view of the horizon'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Therapeutic Procedure
100%
Krukenberg Tumor
100%
Chimeric Antigen Receptor T-Cell Immunotherapy
100%
Ovarian Cancer
75%
Cells
50%
Solid Malignant Neoplasm
50%
Chimeric Antigen Receptor T-Cell
50%
Woman
25%
T Cell
25%
Disease
25%
Malignant Neoplasm
25%
Diagnosis
25%
Neoplasm
25%
Receptor
25%
Face
25%
Cancer
25%
Family
25%
Ligand
25%
Prognosis
25%
Human Leukocyte Antigen
25%
Tumor Antigen
25%
Hematologic Malignancy
25%
Natural Killer Cell Receptor NKG2D
25%
ErbB
25%
Folate Receptor
25%
Therapeutics
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Carcinoma
100%
Leukocyte Antigen
20%